Altimmune, Inc. (LON:0A4C)

Altimmune Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 30, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	362	475	671	268	305	21
Market Cap Growth	190.04%	-29.28%	150.19%	-12.19%	1325.44%	51.42%
Enterprise Value	253	365	504	122	155	-7
Last Close Price	5.38	8.89	13.22	6.83	10.63	-
PS Ratio	8391.84	1418.90	-11888.90	82.35	50.95	4.89
PB Ratio	3.27	3.11	4.36	1.82	1.85	0.62
P/TBV Ratio	3.27	3.11	4.68	1.94	1.96	0.87
EV/Sales Ratio	5256.34	1090.28	-	37.39	25.91	-
Debt / Equity Ratio	0.01	0.00	0.01	0.01	0.01	0.04
Asset Turnover	0.00	0.00	-	0.02	0.05	0.11
Quick Ratio	16.52	16.69	10.99	10.73	18.99	9.91
Current Ratio	16.87	17.26	11.31	11.17	19.16	10.04
Return on Equity (ROE)	-72.96%	-46.63%	-44.07%	-45.69%	-36.14%	-43.74%
Return on Assets (ROA)	-39.56%	-25.00%	-25.73%	-22.86%	-16.10%	-22.71%
Return on Capital (ROIC)	-43.44%	-27.38%	-28.31%	-24.76%	-17.52%	-25.70%
Earnings Yield	-21.35%	-14.63%	-10.48%	-26.74%	-11.76%	-72.31%
FCF Yield	-17.90%	-12.55%	-7.76%	-24.88%	-8.28%	-33.84%
Buyback Yield / Dilution	-32.62%	-13.47%	-13.67%	-61.03%	-95.33%	-368.35%
Total Shareholder Return	-32.62%	-13.47%	-13.67%	-61.03%	-95.33%	-368.35%

Source: S&P Capital IQ. Standard template. Financial Sources.